Last: | $4.805 |
---|---|
Change Percent: | 4.57% |
Open: | $4.58 |
Close: | $4.805 |
High: | $5 |
Low: | $4.55 |
Volume: | 2,265,701 |
Last Trade Date Time: | 03/19/2021 04:10:44 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.805 | $4.58 | $4.805 | $5 | $4.55 | 2,265,701 | 03-19-2021 |
$4.53 | $4.81 | $4.53 | $4.92 | $4.5 | 728,026 | 03-18-2021 |
$3.72 | $3.91 | $3.72 | $4.1 | $3.01 | 2,943,556 | 03-05-2021 |
$3.9 | $4.6 | $3.9 | $4.6131 | $3.77 | 1,369,389 | 03-04-2021 |
$4.33 | $4.66 | $4.33 | $4.78 | $4.24 | 1,126,697 | 03-03-2021 |
$4.55 | $4.97 | $4.55 | $5.13 | $4.47 | 2,720,099 | 03-02-2021 |
$4.88 | $5.13 | $4.88 | $5.24 | $4.87 | 1,267,579 | 03-01-2021 |
$4.92 | $5.24 | $4.92 | $5.59 | $4.92 | 948,246 | 02-26-2021 |
$5.34 | $5.6 | $5.34 | $5.8 | $5.23 | 791,594 | 02-25-2021 |
$5.86 | $5.8 | $5.86 | $6.21 | $5.7173 | 537,357 | 02-24-2021 |
$5.79 | $5.6 | $5.79 | $5.9238 | $5.23 | 1,422,454 | 02-23-2021 |
$6.19 | $6.39 | $6.19 | $6.5 | $5.96 | 1,302,089 | 02-22-2021 |
$6.34 | $5.55 | $6.34 | $6.5 | $5.55 | 1,124,516 | 02-19-2021 |
$6.19 | $6.1 | $6.19 | $6.2917 | $5.6106 | 915,270 | 02-18-2021 |
$6.37 | $6.49 | $6.37 | $6.49 | $6.2 | 923,566 | 02-17-2021 |
$6.5 | $6.07 | $6.5 | $6.53 | $5.85 | 1,846,570 | 02-16-2021 |
$5.92 | $5.69 | $5.92 | $5.97 | $5.51 | 984,674 | 02-15-2021 |
$5.92 | $5.69 | $5.92 | $5.97 | $5.51 | 984,455 | 02-12-2021 |
$5.75 | $6.01 | $5.75 | $6.05 | $5.4 | 1,365,180 | 02-11-2021 |
$5.85 | $6.45 | $5.85 | $6.57 | $5.35 | 2,573,168 | 02-10-2021 |
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Labora...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conferen...